Does fiber help with constipation?

Yes, for adults with chronic constipation, and by a moderate amount. Across 16 randomized trials with 1,251 adults, 66% responded to a fiber supplement against 41% on control, a 48% higher chance of relief (RR 1.48, 95% CI 1.17 to 1.88), and the authors ask for caution because the trials disagreed a lot with each other. The gain showed up at doses above 10 g a day, and among fiber types the effect was significant for psyllium and pectin. In children it has not been shown, and the usual price is more gas.

Established. Fiber supplements help adults with chronic constipation. A meta-analysis of 16 randomized trials found 66% responders against 41%, and an earlier meta-analysis of 7 trials found 77% against 44%, though its authors rated that evidence low quality with a high risk of bias. Both point the same way.

What the trials found

The dose matters

In the 16-trial meta-analysis, doses above 10 g of fiber a day added 1.60 bowel movements a week (95% CI 0.71 to 2.48). Doses of 10 g a day or less made no significant difference. That split comes from a subgroup analysis with very high heterogeneity (I2 85%) and few trials in the low-dose group, so 10 g is a rough line rather than an exact threshold.

The type matters

A 2026 network meta-analysis of 17 randomized trials with 1,423 adults ranked viscous soluble fibers, the group psyllium belongs to, as better than placebo for straining on high certainty evidence. For stool consistency and frequency the certainty was moderate. Insoluble fibers came top for overall symptom score, but on very low certainty. These rankings are probabilities, and the abstract publishes no pooled sizes.

Food or a supplement

In a 2024 meta-analysis of foods for constipation, whole fruit beat a psyllium supplement by 0.36 bowel movements a week (95% CI 0.25 to 0.48) in 232 people, most of them in kiwifruit trials. Prunes did no better or worse than psyllium in that review. A small crossover trial in 40 constipated adults, 37 of them women, gave 1.8 oz (50 g) of prunes twice a day or psyllium at the same 6 g of fiber for 3 weeks each. Prunes gave more complete spontaneous bowel movements and softer stools, with no difference in straining. Prunes also carry sorbitol, so that result is about the fruit and cannot be credited to fiber alone.

In a double-blind trial of 79 adults, agave fructans and psyllium each produced about 70% responders over 8 weeks (73.3%, 71.4%, 70.6% and 69% across four arms). The trial had no placebo arm, so the 70% says the products were similar to each other. It does not say how much better than nothing they were.

Unsettled. Whether fiber from food works as well as the same grams from a supplement has not been tested directly. The fruit comparisons are few and small, and most of the network rankings rest on low to very low certainty.

In people who are not constipated

A review of 113 randomized trials in people with normal bowel function found each extra gram of fiber a day added 0.053 bowel movements a week (95% credible interval 0.042 to 0.065) and softened stools slightly. The evidence was rated moderate, and the numbers come from a model across trials. For someone who already goes regularly, more fiber changes very little about frequency.

Who should be careful

Not for everyone. Expect more gas. In the 16-trial meta-analysis flatulence was clearly higher on fiber than on control (SMD 0.80, 95% CI 0.47 to 1.13), and the earlier review found the same direction. Dry bulk fiber products are a choking risk. US federal rules require psyllium, methylcellulose, guar gum and glucomannan laxatives to warn that taken without enough fluid they can block the esophagus, to tell users to take them with at least 8 ounces of fluid, and to keep them from people who have difficulty swallowing. That rule covers OTC laxative products, not fiber in ordinary food.

Children are a different case. In 9 randomized trials with 680 children aged 1 to 18 with functional constipation, fiber made no significant difference to bowel frequency, stool form, treatment success, soiling or abdominal pain. The trials were weak and varied, so this is an absence of shown benefit rather than proof of none.

In pregnancy, a Cochrane review found fiber raised stool frequency by 2.24 a week (95% CI 0.96 to 3.52), and that figure rests on one trial with 40 women and unclear randomization. Stimulant laxatives worked better in the same review and caused more diarrhea and discomfort.

We searched an interactions database for psyllium and other bulk fibers and found no records. That is a gap in what we could check, and it is not a statement that spacing fiber from medicines does not matter.

What expert bodies say

The 2023 joint guideline of the American Gastroenterological Association and the American College of Gastroenterology gives fiber a conditional recommendation for chronic constipation, alongside lactulose, senna, magnesium oxide and lubiprostone. Its strong recommendations go to polyethylene glycol, sodium picosulfate, linaclotide, plecanatide and prucalopride. We read that guideline at abstract level.

The British Dietetic Association in 2025 strongly recommends psyllium for adults with chronic constipation while rating the evidence low, and finds that polydextrose, inulin mixtures and galacto-oligosaccharides do not help. Its fiber statements rest on the same 16-trial meta-analysis, so it is a second reading of that evidence and adds no new trials.

How we searched

What would change this answer

• A large placebo-controlled psyllium trial comparing several doses over 8 weeks or more, with complete spontaneous bowel movements as the main outcome. That would show whether the 10 g line is real. The trials registry we searched lists no active fiber trial for constipation.
• Adequately sized trials in children, and in constipation caused by opioids or slow transit, where we found no usable trials at all.
• Direct comparisons of fiber from food against the same grams from a supplement.

For the supplement itself, see the psyllium husk page.

Sources

1. ev-fibc-01 · Meta-analysis or systematic review · systematic review and meta-analysis of RCTs · n = 1251
   Overall, 311 of 473 (66%) participants responded to fiber treatment and 134 of 329 (41%) responded to control treatment [RR: 1.48 (95% CI: 1.17, 1.88; P = 0.001); I2 = 57% (P = 0.007)], with psyllium and pectin having significant effects.
   
   Who: adults with chronic constipation in 16 randomized controlled trials; response reported in 9 trials with 802 participants
   Effect: response 311/473 (66%) vs 134/329 (41%), RR 1.48 (95% CI 1.17 to 1.88), I2 57%; stool frequency SMD 0.72 (0.36 to 1.08); consistency SMD 0.32 (0.18 to 0.46)
   Certainty: Cochrane RoB 2.0 used; the authors ask for caution because heterogeneity was considerable. Psyllium and pectin drove the effect.
   Am J Clin Nutr, 2022 · checked 2026-10-06 · we read the abstract
2. ev-fibc-02 · Meta-analysis or systematic review · systematic review and meta-analysis of RCTs, subgroup analysis · n = —
   High fiber doses (>10 g/d) increased stool frequency [MD: +1.60 bowel movements/week (95% CI: 0.71, 2.48 bowel movements/week; P = 0.0004); I2 = 85% (P < 0.00001)], but low fiber doses (≤10 g/d) did not, with a significant subgroup effect (P = 0.07).
   
   Who: adults with chronic constipation, subgroup of RCTs reporting bowel movements per week
   Effect: doses above 10 g/d MD +1.60 bowel movements/week (95% CI 0.71 to 2.48); doses of 10 g/d or less no significant effect
   Certainty: subgroup analysis with I2 85%; few trials in the low-dose group, so the dose threshold is indicative, not exact
   Am J Clin Nutr, 2022 · checked 2026-10-06 · we read the fulltext
3. ev-fibc-03 · Meta-analysis or systematic review · systematic review and meta-analysis of RCTs · n = 287
   Overall, 113 of 147 (77%) patients assigned to fibre responded to therapy, compared with 61 of 140 (44%) allocated to placebo (RR of success to respond 1.71, 95% CI 1.20-2.42, P = 0.003).
   
   Who: adults with chronic idiopathic constipation in 7 randomized controlled trials
   Effect: response 113/147 (77%) vs 61/140 (44%), RR 1.71 (95% CI 1.20 to 2.42); stool frequency SMD 0.39 (0.03 to 0.76)
   Certainty: low quality of evidence and high risk of bias by the authors' own grading; small trials
   Aliment Pharmacol Ther, 2016 · checked 2026-10-06 · we read the abstract
4. ev-fibc-04 · Meta-analysis or systematic review · systematic review and network meta-analysis of RCTs · n = 1423
   NMA suggested that viscous soluble fibers were associated with greater efficacy compared with placebo in relieving defecation difficulty (high certainty, class 1), and were also associated with improvements in stool consistency and stool frequency relative to placebo (moderate certainty, class 1).
   
   Who: adults with chronic idiopathic constipation in 17 randomized controlled trials, searched to October 2025
   Effect: viscous soluble fibers better than placebo for defecation difficulty (high certainty) and for stool consistency and frequency (moderate certainty); insoluble fibers ranked top for overall symptom score on very low certainty
   Certainty: rankings by SUCRA are probabilities, not effect sizes; the abstract gives no pooled numbers
   Food Funct, 2026 · checked 2026-10-06 · we read the abstract
5. ev-fibc-05 · Meta-analysis or systematic review · systematic review of RCTs with Bayesian dose-response modeling · n = 113 trials
   Models provided moderate SoE that increasing fiber intake (per g/d total fiber) yields softening stool consistency [0.013 units, 95% credible interval (CrI): 0.009, 0.016 on the Bristol Stool Scale], increasing total fecal weight (1.76 g/d, 95% CrI: 1.58, 1.94) and dry fecal weight (0.47 g/d, 95% CrI: 0.42, 0.51), increasing fecal frequency (0.053 additional bowel movements/wk, 95% CrI: 0.042, 0.065), and shortening gut transit times (-0.24 h, 95% CrI: -0.36, -0.12).
   
   Who: generally healthy non-infants with normal bowel function in 113 randomized controlled trials, searched to March 2025
   Effect: per g/day total fiber: Bristol scale +0.013 (95% CrI 0.009 to 0.016), fecal weight +1.76 g/d, +0.053 bowel movements/week (0.042 to 0.065), transit -0.24 h
   Certainty: moderate strength of evidence by the authors; findings are model-based and indirect; not about people who are constipated
   Am J Clin Nutr, 2026 · checked 2026-10-06 · we read the abstract
6. ev-fibc-06 · Meta-analysis or systematic review · systematic review and meta-analysis of RCTs · n = 232
   Fruits resulted in higher stool frequency than psyllium (MD: +0.36 bowel movements [BM]/week, [0.25-0.48], n = 232), kiwifruits in particular (MD: +0.36 BM/week, [0.24-0.48], n = 192); there was no difference for prunes compared with psyllium.
   
   Who: adults with chronic constipation; fruit vs psyllium comparison from randomized trials, mostly kiwifruit
   Effect: fruits vs psyllium MD +0.36 bowel movements/week (95% CI 0.25 to 0.48); kiwifruit +0.36 (0.24 to 0.48, n = 192); prunes no different from psyllium
   Certainty: the authors call the evidence on foods scarce; few small trials per food
   Aliment Pharmacol Ther, 2024 · checked 2026-10-06 · we read the abstract
7. ev-fibc-07 · Randomized controlled trial(s) · single-blind randomized crossover trial · n = 40
   The number of complete spontaneous bowel movements per week (primary outcome measure) and stool consistency scores improved significantly (P<0.05) with dried plums when compared to psyllium.
   
   Who: 40 constipated subjects (37 women, mean age 38), dried plums 50 g twice daily or psyllium 11 g twice daily, each 6 g fiber a day, 3 weeks per arm
   Effect: complete spontaneous bowel movements per week and stool consistency improved more with prunes (P<0.05); straining and global symptoms no different
   Certainty: single-blind, small, short arms, almost all women; prunes also carry sorbitol, so the effect is not fiber alone
   Aliment Pharmacol Ther, 2011 · checked 2026-10-06 · we read the abstract
8. ev-fibc-08 · Randomized controlled trial(s) · randomized double-blind controlled trial without placebo arm · n = 79
   The responders were similar across groups (73.3%, 71.4%, 70.6%, and 69%, P >0.050).
   
   Who: 79 patients with functional constipation (62 women), agave fructans 5 or 10 g, agave 5 g plus maltodextrin, or psyllium 5 g plus maltodextrin, once daily for 8 weeks
   Effect: responders 73.3%, 71.4%, 70.6% and 69% across the four arms (P > 0.050); adverse events mild and similar
   Certainty: no placebo arm, so the 70% is not an effect against nothing; product trial with one brand
   J Clin Gastroenterol, 2024 · checked 2026-10-06 · we read the abstract
9. ev-fibc-09 · Meta-analysis or systematic review · systematic review and meta-analysis of RCTs · n = 1251
   Flatulence was higher in fiber groups compared to control groups(SMD: 0.80; 95% CI: 0.47, 1.13; P < 0.00001).
   
   Who: adults with chronic constipation in randomized controlled trials of fiber supplements
   Effect: flatulence SMD 0.80 (95% CI 0.47 to 1.13) vs control
   Certainty: symptom scales differ between trials; the 2016 meta-analysis (27170558) found the same direction, SMD 0.56
   Am J Clin Nutr, 2022 · checked 2026-10-06 · we read the abstract
10. ev-fibc-10 · Position of an expert body · regulation · n = —
    Esophageal obstruction and asphyxiation due to orally-administered drug products containing water-soluble gums, hydrophilic gums, and hydrophilic mucilloids as active ingredients are significant health risks when these products are taken without adequate fluid or when they are used by individuals with esophageal narrowing or dysfunction, or with difficulty in swallowing.
    
    Who: users of OTC drug products with water-soluble or hydrophilic gums and mucilloids, including psyllium, methylcellulose, guar gum and glucomannan, in dry form
    Effect: label must warn of choking and tell users to take the product with at least 8 ounces of fluid; not for people with difficulty swallowing
    Certainty: applies to OTC laxative products, not to fiber in ordinary food
    21 CFR 201.319, Water-soluble gums, hydrophilic gums, and hydrophilic mucilloids (US FDA, eCFR current) · checked 2026-10-06 · we read the section
11. ev-fibc-11 · Meta-analysis or systematic review · systematic review and meta-analysis of RCTs · n = 680
    No statistical significance was observed for bowel movement frequency, stool consistency, therapeutic success, fecal incontinence, and abdominal pain with fiber intake in patients with childhood constipation.
    
    Who: children aged 1 to 18 years with functional constipation in 9 randomized controlled trials
    Effect: no significant difference for bowel movement frequency, stool consistency, therapeutic success, fecal incontinence or abdominal pain
    Certainty: high clinical heterogeneity and weak trials; absence of effect is not proof of no effect
    J Pediatr (Rio J), 2018 · checked 2026-10-06 · we read the abstract
12. ev-fibc-12 · Randomized controlled trial(s) · Cochrane systematic review of RCTs · n = 40
    Pregnant women who received fibre supplementation had significantly higher frequency of stools compared to no intervention (mean difference (MD) 2.24 times per week, 95% CI 0.96 to 3.52; 40 women, one study, moderate quality of evidence).
    
    Who: pregnant women with constipation; fiber supplementation vs no intervention in one study
    Effect: stool frequency MD +2.24 per week (95% CI 0.96 to 3.52), moderate quality
    Certainty: Cochrane review, but the figure comes from a single small trial with unclear randomization, so graded as one RCT; stimulant laxatives worked better than bulk-forming ones but caused more diarrhea and discomfort
    Cochrane Database Syst Rev, 2015 · checked 2026-10-06 · we read the abstract
13. ev-fibc-13 · Position of an expert body · clinical practice guideline · n = —
    Conditional recommendations were made for the use of fiber, lactulose, senna, magnesium oxide, and lubiprostone.
    
    Who: adults with chronic idiopathic constipation, US gastroenterology guideline panel using GRADE
    Effect: conditional recommendation for fiber, lactulose, senna, magnesium oxide and lubiprostone; strong for polyethylene glycol, sodium picosulfate, linaclotide, plecanatide and prucalopride
    Certainty: pharmacological guideline; read at abstract level, full text not in local PMC
    Am J Gastroenterol, 2023 · checked 2026-10-06 · we read the abstract
14. ev-fibc-14 · Position of an expert body · clinical practice guideline · n = —
    1.1 Psyllium supplements increase the number of people with constipation who have a clinical benefit. Level of evidence: low Strength of recommendation: strong
    
    Who: adults with chronic constipation, UK dietetic guideline built on GRADE and Delphi consensus
    Effect: psyllium increases the number with clinical benefit: low evidence, strong recommendation; polydextrose, inulin mixtures and GOS do not
    Certainty: the guideline's fiber statements rest on the same 16-RCT meta-analysis (35816465), so this is not independent evidence
    Neurogastroenterol Motil, 2025 · checked 2026-10-06 · we read the fulltext